Recent studies have revealed that the tumor reprogramming of metabolism is associated with the persistent high expression of glycolysis-related genes, with HIF-1α and c-Myc are considered as the most critical glycolysis-promoting transcription factors [43]. The gene discussed is MYC; the disease is neoplasm.